Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Name of entity: XRF Scientific Limited
ABN: 80 107 908 314
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Vance Stazzonelli |
Date of last notice | 16 October 2020 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Indirect | ||
Nature of indirect interest | Mr Vance Albert Stazzonelli | ||
(including registered holder) | |||
Note: Provide details of the circumstances giving rise to the relevant | Mr Stazzonelli is a beneficiary of the trust | ||
interest. | |||
Date of change | 5 November 2020 | ||
No. of securities held prior to change | 544,266 | ||
Class | Ordinary Shares | ||
Number acquired | 35,734 | ||
Number disposed | Nil | ||
Value/Consideration | $10,184 | ||
Note: If consideration is non-cash, provide details and estimated | |||
valuation | |||
No. of securities held after change | 580,000 | ||
Nature of change | On-market trade | ||
Example: on-market trade, off-market trade, exercise of options, issue | |||
of securities under dividend reinvestment plan, participation in buy- | |||
back | |||
+ See chapter 19 for defined terms.
01/01/2011 | Appendix 3Y Page 1 |
Appendix 3Y
Change of Director's Interest Notice
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change
Part 3 - +Closed period
Were the interests in the securities or contracts detailed above | No |
traded during a +closed period where prior written clearance | |
was required? | |
If so, was prior written clearance provided to allow the trade to | N/A |
proceed during this period? | |
If prior written clearance was provided, on what date was this | N/A |
provided? | |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 | 01/01/2011 |
Attachments
- Original document
- Permalink
Disclaimer
XRF Scientific Limited published this content on 06 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 November 2020 09:55:16 UTC